BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Business

  Octapharma AG Invests €80 Million to Acquire an Exclusive Worldwide License to Certain IP of Glycotope’s Technology

  October 8, 2015

   · 

  2 min read
• Drug Development

  Boehringer Ingelheim’s Investigational Biologic Cleared Skin Better, Faster And For Longer Than Ustekinumab In Phase II Psoriasis Study

  October 8, 2015

   · 

  5 min read
• Deals

  Thoratec Shareholders Approve St. Jude Medical’s Acquisition Of Thoratec

  October 8, 2015

   · 

  2 min read
• Smith & Nephew Inc. Release: Colombian Surgeon Performs First Total Knee Replacement Using Smith & Nephew’s VISIONAIRE Cutting Guides In Latin America

  October 8, 2015

   · 

  4 min read
• Drug Development

  Allergan Anti-Infective Portfolio Highlighted In 13 Abstracts At IDWeek 2015

  October 8, 2015

   · 

  19 min read
• Policy

  PharmAthene, Inc. Announces Conclusion Of Oral Arguments In Its Litigation Against SIGA

  October 8, 2015

   · 

  1 min read
• Drug Development

  CoLucid Pharma Announces Initiation Of Phase III Long-Term, Open-Label Trial Of Lasmiditan In Migraine

  October 8, 2015

   · 

  4 min read
• Business

  Janet S. Vergis Appointed To IMPAX Labs Board Of Directors

  October 8, 2015

   · 

  7 min read
• Policy

  Salix Release: FDA Grants RUCONEST (C1 Esterase Inhibitor [Recombinant]) Twelve-Year Reference Product Exclusivity

  October 8, 2015

   · 

  7 min read
• Drug Development

  Heat Biologics Completes Patient Enrollment For Randomized Arms Of Its Phase II HS-410 Bladder Cancer Trial

  October 8, 2015

   · 

  4 min read